Kevin Harvey is a General Partner and co-founder of Benchmark Capital, one of Silicon Valley's most storied venture capital firms, which he helped launch in 1995 alongside Bob Kagle, Bruce Dunlevie, Andy Rachleff, and Val Vaden. Before turning to investing, Harvey built and sold two software companies - StyleWare (acquired by Apple's Claris in 1988, becoming ClarisWorks) and Approach Software (acquired by Lotus in 1993) - giving him rare operator credibility. At Benchmark, he has backed transformative companies including eBay, Twitter, Upwork, MySQL, OpenTable, and Proofpoint. Outside of venture capital, Harvey is the founder of Rhys Vineyards in the Santa Cruz Mountains, a critically acclaimed winery focused on Pinot Noir and Chardonnay, where he applies the same data-driven rigor to terroir as he does to startup evaluation.
Dr. Dino Dina is a Genoa-born physician-scientist who spent 15 years building Dynavax Technologies as its President and CEO, shepherding the company through the long road toward HEPLISAV-B, a two-dose hepatitis B vaccine whose CpG 1018 adjuvant technology later became a cornerstone of global COVID-19 vaccine programs. Before Dynavax, he built the Vaccine Group at Chiron Corporation and led Chiron Vaccines to the first-ever approval of an adjuvanted influenza vaccine in Italy. Since retiring in 2013, he has poured equal scientific rigor into his Cimarossa estate on Howell Mountain, Napa Valley - 60 mountain acres of vines and 1,200 olive trees named for the Italian phrase meaning 'red hilltop.'